Entrada Therapeutics IPO

Entrada Therapeutics is a drug delivery platform leveraging its proprietary Endosomal Escape Vehicle (EEV)TM platform and creating a diverse and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to efficiently target and engage underlying drivers of diseases.

Register for Details

For more details on financing and valuation for Entrada Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Entrada Therapeutics's ticker symbol?


What is Entrada Therapeutics's stock price?

14.2 as of 9/20/23

Learn more about Entrada Therapeutics

Forge green plus iconForge green minus icon

When was Entrada Therapeutics founded?

Entrada Therapeutics was founded in 2016.
Updated on: Jun 12, 2022